ZOMDF · Zomedica Corp.
Market Cap
$86.24M
Shares
979.95M
Volume · Oct 8
1.8M
Avg daily vol (3M)
780.58K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.09
Open$0.08
Day$0.08–0.09
52W close$0.06–0.15
Avg vol 30d922K
Short int126K · 0.0% float · 1.0d
Short vol54%
Last earningsAug 5, 2026
DataJan 2020–Oct 2026
Filing10-Q · Aug 5
Up next
Next earnings call
Oct 23, 2026
Est · unconfirmed
· in 2 wks
filed Aug 5, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
+29.3%
Trailing year
Short interest
0.0%
Latest settlement · 1.0 days to cover
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Buy
Momentum
Weak
Sentiment
Neutral
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 15.4 · calm
Equity put/call 0.62
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−16%
below
Price vs 50-day avg
+5%
above
RSI (14)
58
neutral
MACD trend
Positive
52-week position
30%
mid-range
Momentum
relative strength
1-month return
+5%
trailing
6-month return
−19%
trailing
YTD return
−14%
this year
Relative strength
−28%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Distributing
2 of 7 funds reported for Sep 30 · net -86 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
0.01% of float · ▬ 0.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
7 holders — mid 3-yr range
Squeeze score
30
low risk · 0–100
Fundamentals
Gross margin
525%
EPS growth
−60%
Y/Y
Free cash flow
$-18.2M
Balance sheet
$61.5M
net cash
Quant / Vol
risk profile
Volatility
69%
annualized · 1-yr
Max drawdown
−52%
past year
ATR
7.6%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−16%
Bearish
Price vs 50-day avg
+5%
Bullish
RSI (14)
58
Neutral
MACD trend
Positive
Bullish
52-week position
30%
Neutral
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Distributing
2 of 7 funds reported for Sep 30 · net -86 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
0.01% of float · ▬ 0.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
7 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $0
Now $0 · 30%
Range high $0
vs 200-day avg -16%
vs 50-day avg +5%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted Non-GAAP EBITDA loss non-GAAP | $4.7M | H1 2026 | — |
| Cash burn | $3.4M | Q2 2026 | — |
| Cash, cash equivalents, and available-for-sale securities | $44.1M | as of June 30, 2026 | — |
| Common shares issued and outstanding | 979,949,668 | as of June 30, 2026 | — |
| Gross margin | 63% | H1 2026 | — |
| Non-GAAP EBITDA loss non-GAAP | $4.7M | H1 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ZOMDF
this stock
Zomedica Corp.
|
$86.24M | -13.8% | +17.4% | — | 0.0% |
|
ABT
Abbott Laboratories
|
$171.55B | -21.4% | +5.7% | 27.6 | 1.1% |
|
MDT
Medtronic plc
|
$112.24B | -8.7% | +8.4% | 21.6 | 1.3% |
|
SYK
Stryker Corp
|
$106.24B | -21.2% | +11.2% | 28.7 | 2.0% |
|
BSX
Boston Scientific Corp
|
$61.07B | -55.9% | +12.5% | 17.1 | 3.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Reducing
Holders
6
- % held
- 0.0%
- Reported
- 2 of 7
- Top holder
- Ancora Advisors LLC
Held
Float
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ZOMDF | +12.1% | +4.8% | -19.4% | +9.9% | -13.8% |
| SPY | +1.3% | +2.1% | +9.0% | +1.5% | +13.5% |
| vs SPY | +10.8% | +2.7% | -28.3% | +8.4% | -27.3% |